RAQUEL
ALMANSA MORA
PROFESORA/PROFESOR PERMANENTE LABORAL
Hospital Universitario La Fe
Valencia, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario La Fe (19)
2022
-
Higher frequency of comorbidities in fully vaccinated patients admitted to the ICU due to severe COVID-19: a prospective, multicentre, observational study
The European respiratory journal, Vol. 59, Núm. 2
-
Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study
Intensive Care Medicine, Vol. 48, Núm. 7, pp. 850-864
-
Methodology of a Large Multicenter Observational Study of Patients with COVID-19 in Spanish Intensive Care Units
Archivos de Bronconeumologia, Vol. 58, pp. 22-31
2021
-
Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients
Translational Research, Vol. 236, pp. 147-159
-
Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma
European Journal of Clinical Investigation, Vol. 51, Núm. 6
-
Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)
Critical Care
-
The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients
Critical Care, Vol. 25, Núm. 1
2020
-
Lymphopenic community acquired pneumonia as signature of severe COVID-19 infection
Journal of Infection
2019
-
Simultaneous depression of immunological synapse and endothelial injury is associated with organ dysfunction in community-acquired pneumonia
Journal of Clinical Medicine, Vol. 8, Núm. 9
2017
-
Immunological profiling to assess disease severity and prognosis in community-acquired pneumonia
The Lancet Respiratory Medicine
-
Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality
EBioMedicine, Vol. 24, pp. 231-236
2014
-
IgA level in plasma as a differential factor for influenza infection in severe viral pneumonia
Journal of Clinical Virology
2013
-
IgM levels in plasma predict outcome in severe pandemic influenza
Journal of Clinical Virology, Vol. 58, Núm. 3, pp. 564-567
2012
-
Immunological monitoring to prevent and treat sepsis
Critical Care
-
Interleukin-6 is a potential biomarker for severe pandemic H1N1 influenza a infection
PLoS ONE, Vol. 7, Núm. 6
2011
2010
-
Host adaptive immunity deficiency in severe pandemic influenza
Critical Care, Vol. 14, Núm. 5
2009
-
Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza
Critical Care, Vol. 13, Núm. 6